E. Gerald Kay - Jun 30, 2023 Form 5 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Executive Chairman & President, Director, 10%+ Owner
Signature
/s/ Christina Kay
Stock symbol
INBP
Transactions as of
Jun 30, 2023
Transactions value $
$0
Form type
5
Date filed
11/16/2023, 04:13 PM
Previous filing
Nov 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBP Common Stock Will/Inheritance $0 -4.3M -100% $0.00* 0 Mar 20, 2023 Direct
transaction INBP Common Stock Will/Inheritance $0 -853K -100% $0.00* 0 Mar 20, 2023 As sole member of LLC or Trustee of Trusts F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Will/Inheritance $0 -150K -100% $0.00* 0 Mar 20, 2023 Common Stock 150K $0.23 Direct F2, F3
transaction INBP Stock Option (right to buy) Will/Inheritance $0 -100K -100% $0.00* 0 Mar 20, 2023 Common Stock 100K $0.72 Direct F2, F3, F4
transaction INBP Stock Option (right to buy) Will/Inheritance $0 -65K -100% $0.00* 0 Mar 20, 2023 Common Stock 65K $1.05 Direct F2, F3, F5
transaction INBP Stock Option (right to buy) Will/Inheritance $0 -100K -100% $0.00* 0 Mar 20, 2023 Common Stock 100K $0.45 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

E. Gerald Kay is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Includes (i) 819,628 shares registered to the name of EGK LLC, an entity the Reporting Person was the sole member of and (ii) 16,697 shares held in each of the Riva Grantor Trust and Christina Kay Grantor Trust whereas the Reporting Person was the Trustee.
F2 The option vested over three years beginning of the first year anniversary noted herein.
F3 Due to the passing of the Reporting Person, the Expiration Date is one year from the date of death.
F4 Includes 33,333 shares that were not vested at the time of the Reporting Person's passing.
F5 Includes 43,333 shares that were not vested at the time of the Reporting Person's passing.
F6 None of the Options were vested at the time of passing of the Reporting Person.